C

Crinetics Pharmaceuticals
D

CRNX

59.690
USD
0.82
(1.39%)
Market Closed
Volume
0
EPS
0
Div Yield
0
P/E
-16
Market Cap
4,777,325,561
Related Instruments
    A
    ALNY
    31.19
    (13.13%)
    268.66 USD
    A
    ARWR
    -1.160
    (-4.06%)
    27.410 USD
    C
    CRBP
    -0.500
    (-0.84%)
    59.160 USD
    E
    EOLS
    1.660
    (13.38%)
    14.070 USD
    M
    MRTX
    0
    (0%)
    0.000000 USD
    R
    RGNX
    -0.920
    (-6.44%)
    13.370 USD
    More
News

Title: Crinetics Pharmaceuticals

Sector: Healthcare
Industry: Biotechnology
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors.